Kendle licences BNA for faster, cheaper brain imaging
Kendle has added brain network activation (BNA) imaging to offer clients a non-invasive platform for investigating electro-physiological activity.
Kendle has added brain network activation (BNA) imaging to offer clients a non-invasive platform for investigating electro-physiological activity.
Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).
CSL Behring is to supply clinical and commercial quantities of plasma-based fibrinogen and thrombin to ProFibrix.
Outsourcing-Pharma presents a round up of the clinical trial technologies unveiled this week at DIA 2010 in Washington, DC, US.
Malaysia is “an ideal location to manufacture generics”, according to F&S, and this could drive growth and investment in the country.
C3i is introducing TechCRO to host clients’ clinical data management systems and provide them with subscriptions to an array of Oracle software.